Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s43440-021-00286-4 http://scihub22266oqcxt.onion/10.1007/s43440-021-00286-4 34085181!8175191!34085181     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pharmacol+Rep 2021 ; 73 (6): 1513-1519 Nephropedia Template TP {{tp|p=34085181|t=2021. Use of glucocorticoids and azithromycin in the therapy of COVID-19 |pdf=|usr=}}{{34085181}} gab.com Text Use of glucocorticoids and azithromycin in the therapy of COVID-19 JO: Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=34085181 #FOAvip In December 2019, a new variant coronavirus, SARS-CoV-2, emerged in China, which was initially described as a pneumonia of an unknown agent. The new coronavirus spreads mainly by person-to-person transmission through close contact. The pathophysiology of COVID-19 is related to a complex immune system response that varies between people and, in severe cases of the disease, is characterized by excessive responses called "cytokine storms," which are associated with complications that can lead to a state of hypercoagulation and death. Glucocorticoids and azithromycin are drugs that may be effective in the treatment. This review aims to highlight the clinical findings that demonstrate the effectiveness of glucocorticoid and azithromycin therapy in the treatment of COVID-19. To date, many drugs have been studied for use in combination therapy, and the rapid expansion of knowledge about the virology of SARS-CoV-2 generates a more accurate direction in therapy. Twit Text FOAVip Use of glucocorticoids and azithromycin in the therapy of COVID-19 ????Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=34085181 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34085181 #FOAvip English Wikipedia <ref>{{Cite pmid|34085181}}</ref> Use of glucocorticoids and azithromycin in the therapy of COVID-19 #MMPMID34085181 de Lemos Neto M; Alexandre RCV; Morra ROG; da Paz JAS; Barroso SPC; Resende AC; de Medeiros-Lima DJM; Alexandre PCB Pharmacol Rep 2021[Dec]; 73 (6): 1513-1519 PMID34085181show ga In December 2019, a new variant coronavirus, SARS-CoV-2, emerged in China, which was initially described as a pneumonia of an unknown agent. The new coronavirus spreads mainly by person-to-person transmission through close contact. The pathophysiology of COVID-19 is related to a complex immune system response that varies between people and, in severe cases of the disease, is characterized by excessive responses called "cytokine storms," which are associated with complications that can lead to a state of hypercoagulation and death. Glucocorticoids and azithromycin are drugs that may be effective in the treatment. This review aims to highlight the clinical findings that demonstrate the effectiveness of glucocorticoid and azithromycin therapy in the treatment of COVID-19. To date, many drugs have been studied for use in combination therapy, and the rapid expansion of knowledge about the virology of SARS-CoV-2 generates a more accurate direction in therapy. |*COVID-19 Drug Treatment[MESH] |Azithromycin/*therapeutic use[MESH] |COVID-19/physiopathology[MESH] |Drug Combinations[MESH] |Glucocorticoids/*therapeutic use[MESH] |Humans[MESH]Use of glucocorticoids and azithromycin in the therapy of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing